Results 311 to 320 of about 289,586 (356)

Corrigendum: A self-assembled nanoparticle vaccine elicits effective neutralizing antibody response against EBV infection. [PDF]

Front Immunol
Li P, Jiang Z, Shi J, Sha H, Yu Z, Zhao Y, Han S, Ma L.   +7 more
europepmc   +1 more source

Neutralizing antibody response to Omicron subvariants BA.1 and BA.5 in children and adolescents following the two-dose CoronaVac protocol (Immunita-002, Brazil): a 12-month longitudinal study. [PDF]

Front Immunol
Corsini CA, Campos GRF, Martins PFDS, Filgueiras PS, Lima AES, Gomes SVC, Curimbaba CAL, Lorencini DA, Morandi Junior E, da Silva VM, Cervi MC, Borges MC, de Lima PR, do Nascimento JPR, Correa PRL, Castilho LDR, de Oliveira JG, Filho OAM, Nogueira ML, Grenfell RFQE.   +19 more
europepmc   +1 more source

How a paramyxovirus fusion/entry complex adapts to escape a neutralizing antibody. [PDF]

Nat Commun
Marcink TC, Zipursky G, Sobolik EB, Golub K, Herman E, Stearns K, Greninger AL, Porotto M, Moscona A.   +8 more
europepmc   +1 more source

Human adenovirus species B knob proteins as immunogens for inducing cross-neutralizing antibody responses. [PDF]

mSphere
Liu Z, Xian Y, Lan J, Zhou Z, Li X, Zhou R, Chen D, Tian X.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Broadly Neutralizing Antiviral Antibodies

Annual Review of Immunology, 2013
A fascinating aspect of viral evolution relates to the ability of viruses to escape the adaptive immune response. The widely held view has been that the great variability of viral glycoproteins would be an absolute obstacle to the development of antibody-based therapies or vaccines that could confer broad and long-lasting protection.
Corti D., Lanzavecchia A.
openaire   +3 more sources

Production of Neutralizing Antibody

2018
Techniques employing monoclonal antibodies (mAbs) are widely used in the initial development phase of biologics. The usefulness of mAbs in basic RA research has been established based on their characteristics, including specificity of binding, homogeneity, and ability to be produced on a large scale.
Erika Takemasa, Hitoshi Hasegawa, Shuang Liu   +2 more
openaire   +2 more sources

Neutralization of HIV by Antibodies

2008
Antibodies can neutralize HIV-1 with potency and cross-reactivity that varies widely and is related but not correlated to their antigen-binding affinity. Therefore, in addition to measuring binding affinity, an evaluation of the antibody neutralizing activity in tissue cultures is important for development of antibody-based therapeutics, design of ...
Ilia Prado, Timothy R. Fouts, Antony S. Dimitrov   +2 more
openaire   +3 more sources

Testing for neutralizing antibodies

British Journal of Neuroscience Nursing, 2007
Interferon-beta drugs for multiple sclerosis sometimes give rise to immune proteins that neutralize their effects. Nicola O'Connell and Bronwen Roper look at testing for these neutralizing antibodies
Nicola O'Connell, Bronwen Roper
openaire   +2 more sources

Neutralizing antibodies to interferon

Neurology, 2007
The impact of neutralizing antibodies (NAbs) to interferon-beta (IFN-beta) on clinical and imaging parameters in multiple sclerosis (MS) is reviewed. An effect on relapse rates and imaging parameters was noted in patients who tested positive for NAbs, but disability measures were unaffected or showed a trend toward improvement.
openaire   +3 more sources